{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T06:40:49Z","timestamp":1785652849931,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013171","name":"Public Interest Incorporated Foundation Ryobi Teien Memory Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0109673"],"award-info":[{"award-number":["JP23ek0109673"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP256f0137010"],"award-info":[{"award-number":["JP256f0137010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jns.2026.125733","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:38:45Z","timestamp":1767685125000},"page":"125733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The utility of Gold Coast criteria for amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"481","author":[{"given":"Emi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Morihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Osakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijun","family":"Yunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jns.2026.125733_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"Brooks","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125733_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.jns.2026.125733_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17482960802521126","article-title":"Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis","volume":"10","author":"Carvalho","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2026.125733_bb0020","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review","volume":"69","author":"Costa","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125733_bb0030","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.clinph.2016.04.005","article-title":"Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data","volume":"127","author":"Geevasinga","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125733_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinph.2018.11.021","article-title":"Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity","volume":"130","author":"Johnsen","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125733_bb0040","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125733_bb0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ana.26045","article-title":"Diagnostic utility of Gold Coast criteria in amyotrophic lateral sclerosis","volume":"89","author":"Hannaford","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-021-00253-2","article-title":"The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population","volume":"10","author":"Shen","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.jns.2026.125733_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mus.27660","article-title":"Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis","volume":"66","author":"Jewett","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125733_bb0060","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.clinph.2021.08.014","article-title":"Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis","volume":"132","author":"Pugdahl","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125733_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/21678421.2024.2303062","article-title":"Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia","volume":"25","author":"Otani","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemp. Degen."},{"key":"10.1016\/j.jns.2026.125733_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125733_bb0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/21678421.2014.990036","article-title":"Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients","volume":"16","author":"Watanabe","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemp. Degen."},{"key":"10.1016\/j.jns.2026.125733_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jns.2026.125733_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/21678421.2021.1905847","article-title":"Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta","volume":"22","author":"Farrugia Wismayer","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemp. Degen."},{"key":"10.1016\/j.jns.2026.125733_bb0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jnnp-2012-304724","article-title":"Lifetime physical activity and the risk of amyotrophic lateral sclerosis","volume":"84","author":"Huisman","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2026.125733_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jns.2026.125733_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","article-title":"A revision of the El Escorial criteria - 2015","volume":"16","author":"Ludolph","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemp. Degen."},{"key":"10.1016\/j.jns.2026.125733_bb0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jns.2026.125733_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Group EM-AS","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2026.125733_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/21678421.2017.1364269","article-title":"Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis","volume":"18","author":"group EM-As","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemp. Degen."},{"key":"10.1016\/j.jns.2026.125733_bb0135","first-page":"14","article-title":"Improved long-term survival with Edaravone therapy in patients with amyotrophic lateral sclerosis: a retrospective single-Center study in Japan","author":"Houzen","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jns.2026.125733_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ensci.2018.05.001","article-title":"Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis","volume":"11","author":"Okada","year":"2018","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jns.2026.125733_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis: a randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:23:50Z","timestamp":1774275830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"alternative-id":["S0022510X26000146"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125733","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of Gold Coast criteria for amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125733"}}